Pennesi, E., Brivio, E., Willemse, M. E., Huitema, A. D. R., Chandra, S., Vijayakumar, A., Van Der Velden, V. H. J., Beverloo, H. B., Durairaj, C., Viqueira, A., Ingrosso, A., Locatelli, F., Motwani, J., Bourquin, J.-P., Bautista Sirvent, F. J., Rizzari, C., Petit, A., Lancaster, D., Metzler, M., … Zwaan, C. M. (2021). A Phase I/II Study of Bosutinib in Pediatric Patients with Resistant/Intolerant or Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia, Study ITCC (Innovative Therapies for Children with Cancer European Consortium) 054 and COG (Children’s Oncology Group Consortium) AAML1921: Results from the Phase I Trial in Resistant/Intolerant Patients. Blood, 138(Supplement 1), 2558–2558. https://doi.org/10.1182/blood-2021-145709
Subjects:
Efficacy and Resistance in CML Treatment
(OpenAlex Topic)
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia
(OpenAlex Topic)
Epidemiology and Treatment of Childhood Leukemia
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1182/blood-2021-145709
Journal:
Publication Date:
Data Source:
OpenAlex
Source Link: